Pioglitazone
پیوگلیتازون
🍽️ Alimentary Tract And MetabolismThiazolidinedione
Market / country: 🇺🇸 USA
Actos (US)
🧮 Dose calculator
Type 2 diabetes mellitus · Regimen source: FDA Pioglitazone (2) · 2.1FDA Pioglitazone (2) · 2
- • NYHA I–II heart failure: start 15 mg. Increase by 15 mg up to 45. With gemfibrozil or strong CYP2C8 inhibitors max 15 mg. FDA Pioglitazone (2) · 2FDA Pioglitazone (2) · 2.3
Enter age (weight is optional for this regimen).
🛡️ Safety & information
Contraindications
- ⛔ Boxed warning: initiation in NYHA class III or IV heart failure is contraindicated. FDA Pioglitazone (2) · Boxed Warning
Formulations
- 15 mg tablet — tablet 🇺🇸 USA FDA Pioglitazone · 3
- 30 mg tablet — tablet 🇺🇸 USA FDA Pioglitazone · 3
- 45 mg tablet — tablet 🇺🇸 USA FDA Pioglitazone · 3
👥 Special populations
- 🤰 PregnancyUse with caution
Label states no clear risk or has limited data; use only if needed, under medical advice. FDA Pioglitazone (2) · 8.1
“Risk Summary Limited data with pioglitazone in pregnant women are not sufficient to determine a drug-associated risk for major birth defects or miscarriage.”
- 🤱 BreastfeedingUse with caution
Label: use with caution while breastfeeding; see the label text. FDA Pioglitazone (2) · 8.2
“Risk Summary There is no information regarding the presence of pioglitazone in human milk, the effects on the breastfed infant, or the effects on milk production.”
- 👶 ChildrenSafety not established
Label: safety and effectiveness in children have not been established. FDA Pioglitazone (2) · 8.4
“Safety and effectiveness of pioglitazone in pediatric patients have not been established.”
- 👴 Older adultsUse with caution
Label: use with caution in older adults, usually starting at the low end of the dose range. FDA Pioglitazone (2) · 8.5
“A total of 92 patients (15.2%) treated with pioglitazone in the three pooled 16- to 26-week double-blind, placebo-controlled, monotherapy trials were ≥65 years old and two patients (0.3%) were ≥75 years old.”
- ⚥ Females & males of reproductive potentialUse with caution
Label has advice on pregnancy testing, contraception or fertility for females and males. FDA Pioglitazone (2) · 8.3
“Discuss the potential for unintended pregnancy with premenopausal women as therapy with pioglitazone, like other thiazolidinediones, may result in ovulation in some anovulatory women.”
🔗 Reference links
- FDA (approval record)ANDA200268
- DailyMed (FDA label)FDA Pioglitazone (2)FDA Pioglitazone
- MedlinePlus (NIH)Pioglitazone
- WHO ATC/DDDA10BG03
- Darooyab (Iran)Pioglitazone
🇮🇷 Registered in Iran Darooyab · G-646/Pioglitazone
Dosage forms with Iranian generic codes, per Darooyab.
- 05624 · PIOGLITAZONE 15MG TAB · قرص پیوگلیتازون ۱۵ میلیگرم
- 05217 · PIOGLITAZONE 30MG TAB · قرص پیوگلیتازون ۳۰ میلیگرم
- 05625 · PIOGLITAZONE 45MG TAB · قرص پیوگلیتازون ۴۵ میلیگرم
📚 Reference status for this drug
Shows which sources have references recorded for this drug and which do not.
- FDA label (DailyMed)✅ PresentFDA Pioglitazone · 3FDA Pioglitazone (2) · 2.1FDA Pioglitazone (2) · 2FDA Pioglitazone (2) · 2.3FDA Pioglitazone (2) · 8.4FDA Pioglitazone (2) · Boxed WarningFDA Pioglitazone (2) · 8.1FDA Pioglitazone (2) · 8.2FDA Pioglitazone (2) · 8.5FDA Pioglitazone (2) · 8.3FDA Pioglitazone (2) · SPL approval / marketing category
- UK SmPC (eMC / MHRA)❌ Not present
- Published guideline❌ Not present
- Licensed reference (medical school)❌ Not present
- Iranian leaflet (IFDA)❌ Not present
- Pharmacy website (secondary, unreliable)✅ PresentDarooyab · G-646/Pioglitazone
- Clinical review⚠ Unverified